CH536815A - Verfahren zur Herstellung von Phenyläthylamin-Derivaten - Google Patents

Verfahren zur Herstellung von Phenyläthylamin-Derivaten

Info

Publication number
CH536815A
CH536815A CH802170A CH802170A CH536815A CH 536815 A CH536815 A CH 536815A CH 802170 A CH802170 A CH 802170A CH 802170 A CH802170 A CH 802170A CH 536815 A CH536815 A CH 536815A
Authority
CH
Switzerland
Prior art keywords
preparation
phenylethylamine derivatives
phenylethylamine
derivatives
Prior art date
Application number
CH802170A
Other languages
English (en)
Inventor
Jack David
Hartley David
Charles Lunts Lawrence Henry
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of CH536815A publication Critical patent/CH536815A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH802170A 1969-05-30 1970-05-29 Verfahren zur Herstellung von Phenyläthylamin-Derivaten CH536815A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB27407/69A GB1263987A (en) 1969-05-30 1969-05-30 Phenethylamine derivatives

Publications (1)

Publication Number Publication Date
CH536815A true CH536815A (de) 1973-05-15

Family

ID=10259075

Family Applications (1)

Application Number Title Priority Date Filing Date
CH802170A CH536815A (de) 1969-05-30 1970-05-29 Verfahren zur Herstellung von Phenyläthylamin-Derivaten

Country Status (11)

Country Link
US (1) US3689524A (de)
JP (2) JPS5330701B1 (de)
BE (1) BE751190A (de)
CA (1) CA960690A (de)
CH (1) CH536815A (de)
DK (1) DK130921B (de)
FR (1) FR2051566B1 (de)
GB (1) GB1263987A (de)
NL (1) NL7007861A (de)
SE (1) SE372934B (de)
ZA (1) ZA703451B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231858B1 (de) * 1969-12-17 1977-08-17
US4120978A (en) * 1970-01-08 1978-10-17 Ciba-Geigy Corporation Pharmaceutical composition for inhibiting and blocking cardioselective beta-receptors
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US3935259A (en) * 1970-01-08 1976-01-27 Ciba-Geigy Corporation New amines and processes for their manufacture
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
US3976783A (en) * 1970-07-18 1976-08-24 Pfizer Inc. Method of stimulating the heart employing ureido substituted phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
US3972919A (en) * 1970-12-17 1976-08-03 Smithkline Corporation p-Hydroxymethylphenylglycine
US3862222A (en) * 1971-01-11 1975-01-21 Smithkline Corp {60 amino-4-benzyloxy-3-ureidoacetophenones
BE794414A (fr) * 1972-01-25 1973-07-23 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicament
US4024281A (en) * 1972-05-26 1977-05-17 Smithkline Corporation N,N-bis[2-(3-substituted-4-hydroxyphenyl)-ethyl or -2-hydroxyethyl]-polymethylenediamines
US4035420A (en) * 1972-07-06 1977-07-12 Aktiebolaget Hassle Substituted ureido alkylene phenoxy propanolamines
US4000197A (en) * 1973-07-23 1976-12-28 The University Of Iowa Research Foundation Asymmetric synthesis of phenylisopropylamines
NL7404732A (nl) * 1974-04-08 1975-10-10 Philips Nv Spasmolytice.
US4163060A (en) * 1974-04-08 1979-07-31 U.S. Philips Corporation Aralkylamino carboxylic acids and derivatives having spasmolytic activity
US4145363A (en) * 1975-02-05 1979-03-20 Yamanouchi Pharmaceutical Co., Ltd. 4-Carbamoylamino-α-aminomethylbenzyl alcohol derivatives
US4958026A (en) * 1984-08-15 1990-09-18 Schering Aktiengesllschaft Novel dopamine derivatives, processes for their preparation, and their use as medicinal agents
US4629730A (en) * 1985-04-11 1986-12-16 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
US4847269A (en) * 1985-04-11 1989-07-11 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
US4642378A (en) * 1985-04-11 1987-02-10 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4752621A (en) * 1985-04-11 1988-06-21 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ATE287390T1 (de) 1994-10-21 2005-02-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ATE430123T1 (de) 1996-05-01 2009-05-15 Nps Pharma Inc Inorganische am ionen-rezeptor aktive verbindungen
GB201208775D0 (en) 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds

Also Published As

Publication number Publication date
BE751190A (fr) 1970-11-30
SE372934B (de) 1975-01-20
GB1263987A (en) 1972-02-16
DK130921C (de) 1975-10-06
JPS547782B1 (de) 1979-04-10
FR2051566A1 (de) 1971-04-09
FR2051566B1 (de) 1974-02-22
CA960690A (en) 1975-01-07
DE2026402A1 (de) 1970-12-03
ZA703451B (en) 1971-01-27
DK130921B (da) 1975-05-05
NL7007861A (de) 1970-12-02
JPS5330701B1 (de) 1978-08-29
DE2026402B2 (de) 1977-06-02
US3689524A (en) 1972-09-05

Similar Documents

Publication Publication Date Title
CH536815A (de) Verfahren zur Herstellung von Phenyläthylamin-Derivaten
AT298508B (de) Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen
CH539642A (de) Verfahren zur Herstellung von Pyrimidinylpyrazolderivaten
AT302277B (de) Verfahren zur Herstellung von Chinondiiminen
CH526566A (de) Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen
CH508604A (de) Verfahren zur Herstellung von Ureidophenylguanidinen
CH521934A (de) Verfahren zur Herstellung von Buten-2-ol-4-Derivaten
CH543479A (de) Verfahren zur Herstellung von Phenyläthylaminderivaten
AT304774B (de) Verfahren zur Herstellung von 16β-Methyl-9α-fluor-steroiden
CH525881A (de) Verfahren zur Herstellung von 4-Alkylprolinen
CH505041A (de) Verfahren zur Herstellung von Cycloalkenonen
AT319485B (de) Verfahren zur Herstellung von 19-Norsteroiden
AT296961B (de) Verfahren zur Herstellung von Alkyldihydroxybenzolen
CH511225A (de) Verfahren zur Herstellung von Amidophenylthioharnstoffen
CH529108A (de) Verfahren zur Herstellung von y-Cyanbutyraldiminen
CH538469A (de) Verfahren zur Herstellung von substituierten Tetralonen
CH523903A (de) Verfahren zur Herstellung von substituierten 3-Amino-benzothiophenen
CH543486A (de) Verfahren zur Herstellung von Malononitrilderivaten
AT308086B (de) Verfahren zur Herstellung von 1-Alkoxyanthrachinonen
CH530408A (de) Verfahren zur Herstellung von Chinolylpiperazinen
CH532069A (de) Verfahren zur Herstellung von 3-Hydroxyisoxazolderivaten
AT305503B (de) Verfahren zur herstellung von neuem 9alpha-fluor-16-fluormethylen-prednisolon-21-oenanthat
AT299905B (de) Verfahren zur Herstellung von β-Acetoxypivalinaldehyd
AT296297B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH530358A (de) Verfahren zur Herstellung von 2-Methyl-4-halogen-but-2-en-1-alen

Legal Events

Date Code Title Description
PL Patent ceased